Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Epigenetic repression of the dopamine receptor D4 in pediatric tumors of the central nervous system.
EZH2 appears to dominate over aberrant DNA methylation in the epigenetic inhibition of DRD4.
»
06/06/13
18beta-glycyrrhetinic acid induces apoptosis in pituitary adenoma cells via ROS/MAPKs-mediated pathway.
CaMKII may serve a linkage between ROS accumulation and the activation of JNK and P38.
»
05/15/13
Underexpression of miR-126 and miR-20b in hereditary and nonhereditary colorectal tumors.
Underexpression of miR-126 and miR-20b occurs as an early event of colorectal carcinogenesis in FAP tumors.
»
03/31/14
Relationship between aspirin use after diagnosis of colorectal cancer and patient survival: a meta-analysis of observational studies.
Use of aspirin after diagnosis does not reduce colorectal cancer-specific mortality.
»
05/16/14
Peroxisome proliferator-activated receptor γ ligand troglitazone and TRAIL synergistically induce apoptosis.
Co-treatment with troglitazone induced apoptosis through DR5 upregulation in human colon cancer DLD-1 cells.
»
09/19/13
Grape Seed Proanthocyanidins (GSPs) Inhibit the Growth of Cervical Cancer by Inducing Apoptosis Mediated by the Mitochondrial Pathway.
Underlying mechanism was associated with increased expression of the pro-apoptotic protein Bak-1.
»
09/03/14
Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance.
NErbB-2 as the major proliferation driver in Ttzm-resistant BC.
»
05/12/14
The effects of soy supplementation on gene expression in breast cancer: a randomized placebo-controlled study.
In a subset of women, soy could adversely affect gene expression in breast cancer.
»
09/04/14
MiR-34a regulates therapy resistance by targeting HDAC1 and HDAC7 in breast cancer.
miR-34a-HDAC1/HDAC7-HSP70 K246 axis as a novel molecular signature predictive of therapy resistance.
»
07/24/14
High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer.
BRCA1/2 mutation carriers treated with BCT have a high risk of LR, many of which are new primary breast cancers.
»
08/19/14
< Prev
Next >